Back to search
FDAFDA · Food and drugs·Recall number Z-1001-2013

Sepp, Compound Benzoin Tincture Packaged and Tincture 3,000 Bulk. Product Usage: Preoperative skin product

Published April 3, 2013 · Recall initiated: March 4, 2013

Summary

FDA records medical device Class III recall Z-1001-2013, published April 3, 2013 and initiated March 4, 2013. Recalling firm: CareFusion 213, LLC; Status: Terminated; Reported quantity: 13,749,000; Lot: Tincture Packaged: Product Number 260619 and Product ID D086353; Tincture 3,000 Bulk: Product Number 260520 and Product ID D086353. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

An internal review of CareFusion's labeling for preoperative skin prep product codes was recently conducted. The labeling of the product codes identified above state that the contents of the package are sterile and does not clarify that this sterility claim is only applicable to the applicator. The antiseptic solution that is applied to the skin is a cutaneous disinfectant, and is not sterilized.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
CareFusion 213, LLC
Distributor
USA Nationwide Distribution
Lot
Tincture Packaged: Product Number 260619 and Product ID D086353; Tincture 3,000 Bulk: Product Number 260520 and Product ID D086353.
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Sepp, Compound Benzoin Tincture Packaged and Tincture 3,000 Bulk. Product Usage: Preoperative skin product recalled?

Yes. FDA published recall Z-1001-2013 on April 3, 2013. Reported hazard: An internal review of CareFusion's labeling for preoperative skin prep product codes was recently conducted. The labeling of the product codes identified above state that the contents of the package are sterile and does not clarify that this sterility claim is only applicable to the applicator. The antiseptic solution that is applied to the skin is a cutaneous disinfectant, and is not sterilized.

What should I do if I have this product?

Voluntary: Firm initiated · Letter